{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:05:04Z","timestamp":1789549504643,"version":"build-2803163510"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2010,8,5]],"date-time":"2010-08-05T00:00:00Z","timestamp":1280966400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0011986","type":"journal-article","created":{"date-parts":[[2010,8,5]],"date-time":"2010-08-05T15:53:19Z","timestamp":1281023599000},"page":"e11986","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":122,"title":["The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)"],"prefix":"10.1371","volume":"5","author":[{"given":"Johannes","family":"Brettschneider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Czerwoniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makbule","family":"Senel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kassubek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmar","family":"Pinkhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Lauda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Kapfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Jesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Lehmensiek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert C.","family":"Ludolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayrettin","family":"Tumani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2010,8,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1474-4422(05)70071-5","article-title":"Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis.","volume":"4","author":"D Miller","year":"2005","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d.","volume":"58","author":"CH Polman","year":"2005","journal-title":"Ann Neurol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1212\/01.wnl.0000277704.56189.85","article-title":"Clinically isolated syndromes: predicting and delaying multiple sclerosis.","volume":"68","author":"BW Thrower","year":"2007","journal-title":"Neurology"},{"key":"ref4","article-title":"The risk of relapse after a clinically isolated syndrome is related to the pattern of oligoclonal bands.","author":"I Bosca","year":"2010","journal-title":"J Neuroimmunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/brain\/awq035","article-title":"Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis.","volume":"133","author":"M Comabella","year":"2010","journal-title":"Brain"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/1352458509359725","article-title":"Neurofilament light as a prognostic marker in multiple sclerosis.","volume":"16","author":"J Salzer","year":"2010","journal-title":"Mult Scler"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/ana.20890","article-title":"B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation.","volume":"59","author":"E Meinl","year":"2006","journal-title":"Ann Neurol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1212\/01.wnl.0000280576.73609.c6","article-title":"Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?","volume":"70","author":"M Tintore","year":"2008","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e7638","DOI":"10.1371\/journal.pone.0007638","article-title":"IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome.","volume":"4","author":"J Brettschneider","year":"2009","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1074-7613(01)00118-2","article-title":"Chemokines, chemokine receptors, and allograft rejection.","volume":"14","author":"PJ Nelson","year":"2001","journal-title":"Immunity"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1212\/WNL.0b013e3181c5b457","article-title":"Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS.","volume":"73","author":"F Sellebjerg","year":"2009","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/brain\/awh680","article-title":"Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.","volume":"129","author":"M Krumbholz","year":"2006","journal-title":"Brain"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e2559","DOI":"10.1371\/journal.pone.0002559","article-title":"Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis.","volume":"3","author":"B Kuenz","year":"2008","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/brain\/120.11.2059","article-title":"Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis.","volume":"120(Pt 11)","author":"F Barkhof","year":"1997","journal-title":"Brain"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).","volume":"33","author":"JF Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1468-2982.2005.00878.x","article-title":"The International Classification of Headache Disorders, 2nd Edition (ICHD-II)\u2013revision of criteria for 8.2 Medication-overuse headache.","volume":"25","author":"SD Silberstein","year":"2005","journal-title":"Cephalalgia"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","article-title":"A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.","volume":"73","author":"CE Teunissen","year":"2009","journal-title":"Neurology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-510X(00)00501-3","article-title":"Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs.","volume":"184","author":"H Reiber","year":"2001","journal-title":"J Neurol Sci"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1515\/CCLM.2001.051","article-title":"Reporting cerebrospinal fluid data: knowledge base and interpretation software.","volume":"39","author":"H Reiber","year":"2001","journal-title":"Clin Chem Lab Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1515\/CCLM.2003.053","article-title":"Quality assurance for cerebrospinal fluid protein analysis: international consensus by an Internet-based group discussion.","volume":"41","author":"H Reiber","year":"2003","journal-title":"Clin Chem Lab Med"},{"key":"ref21","first-page":"99","article-title":"Cerebrospinal fluid\u2013physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases.","volume":"4","author":"H Reiber","year":"1998","journal-title":"Mult Scler"},{"key":"ref22","article-title":"The intrathecal, polyspecific antiviral immune response: Specific for MS or a general marker of CNS autoimmunity?","author":"S Jarius","year":"2008","journal-title":"J Neurol Sci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1136\/jnnp.2007.133330","article-title":"Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica.","volume":"79","author":"S Jarius","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref24","article-title":"The chemokine CXCL13 in acute neuroborreliosis.","author":"M Senel","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/bmj.304.6823.381-c","article-title":"Confidence intervals: enlightening or mystifying?","volume":"304","author":"RG Newcombe","year":"1992","journal-title":"BMJ"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests.","volume":"3","author":"WJ Youden","year":"1950","journal-title":"Cancer"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1177\/1352458509107017","article-title":"Serum levels of CXCL13 are elevated in active multiple sclerosis.","volume":"15","author":"ED Festa","year":"2009","journal-title":"Mult Scler"},{"key":"ref28","first-page":"549","article-title":"Impact of methylprednisolone treatment on the expression of macrophage inflammatory protein 3alpha and B lymphocyte chemoattractant in serum of multiple sclerosis patients.","volume":"60","author":"G Michalowska-Wender","year":"2008","journal-title":"Pharmacol Rep"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nri1130","article-title":"Three or more routes for leukocyte migration into the central nervous system.","volume":"3","author":"RM Ransohoff","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1084\/jem.193.12.1373","article-title":"Subspecialization of CXCR5+ T cells: B helper activity is focused in a germinal center-localized subset of CXCR5+ T cells.","volume":"193","author":"CH Kim","year":"2001","journal-title":"J Exp Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/35018581","article-title":"A chemokine-driven positive feedback loop organizes lymphoid follicles.","volume":"406","author":"KM Ansel","year":"2000","journal-title":"Nature"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000082086","article-title":"Regulatory roles for cytokine-producing B cells in infection and autoimmune disease.","volume":"8","author":"FE Lund","year":"2005","journal-title":"Curr Dir Autoimmun"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0092-8674(00)81113-7","article-title":"Nerve growth factor is an autocrine survival factor for memory B lymphocytes.","volume":"85","author":"M Torcia","year":"1996","journal-title":"Cell"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.it.2005.10.003","article-title":"Understanding the IL-23-IL-17 immune pathway.","volume":"27","author":"BS McKenzie","year":"2006","journal-title":"Trends Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1212\/01.wnl.0000171349.06645.79","article-title":"The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis.","volume":"65","author":"TA Rupprecht","year":"2005","journal-title":"Neurology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"5968","DOI":"10.1158\/1078-0432.CCR-09-0108","article-title":"CXCL13 and CXCL12 in central nervous system lymphoma patients.","volume":"15","author":"L Fischer","year":"2009","journal-title":"Clin Cancer Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1191\/135248506ms1263oa","article-title":"Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis.","volume":"12","author":"J Brettschneider","year":"2006","journal-title":"Mult Scler"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1474-4422(06)70353-2","article-title":"MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study.","volume":"5","author":"T Korteweg","year":"2006","journal-title":"Lancet Neurol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1056\/NEJMoa063602","article-title":"Lack of association between antimyelin antibodies and progression to multiple sclerosis.","volume":"356","author":"J Kuhle","year":"2007","journal-title":"N Engl J Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S1474-4422(07)70176-X","article-title":"MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study.","volume":"6","author":"JK Swanton","year":"2007","journal-title":"Lancet Neurol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/bmj.38771.583796.7C","article-title":"Accuracy of magnetic resonance imaging for the diagnosis of multiple sclerosis: systematic review.","volume":"332","author":"P Whiting","year":"2006","journal-title":"BMJ"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0009-8981(01)00573-3","article-title":"Dynamics of brain-derived proteins in cerebrospinal fluid.","volume":"310","author":"H Reiber","year":"2001","journal-title":"Clin Chim Acta"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jneuroim.2008.06.004","article-title":"Oligoclonal IgG band patterns in inflammatory demyelinating human and mouse diseases.","volume":"200","author":"D Franciotta","year":"2008","journal-title":"J Neuroimmunol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0011986","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T23:36:44Z","timestamp":1540251404000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0011986"}},"subtitle":[],"editor":[{"given":"Christoph","family":"Kleinschnitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,8,5]]},"references-count":43,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2010,8,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0011986","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,5]]}}}